Cargando…
Global Immunization Challenge: Progress and Opportunities
After reading this chapter and answering the discussion questions that follow, you should be able to: Outline important milestones in the emergence of vaccines as a means of disease control and prevention. Discuss factors that underpin the disparity in access to vaccines between rich and poor countr...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176199/ http://dx.doi.org/10.1007/b106524_23 |
_version_ | 1783524974901854208 |
---|---|
author | Affolder, Rebecca Zaffran, Michel Lob-Levyt, Julian |
author_facet | Affolder, Rebecca Zaffran, Michel Lob-Levyt, Julian |
author_sort | Affolder, Rebecca |
collection | PubMed |
description | After reading this chapter and answering the discussion questions that follow, you should be able to: Outline important milestones in the emergence of vaccines as a means of disease control and prevention. Discuss factors that underpin the disparity in access to vaccines between rich and poor countries. Identify and appraise innovative options for financing vaccine development, and for ensuring wider access to new and underused vaccines in developing countries. Evaluate strategies for ensuring sustainability in vaccine development, management, and access. Outline priorities for future research, policy, and practice with regard to vaccine development, procurement, and access. |
format | Online Article Text |
id | pubmed-7176199 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
record_format | MEDLINE/PubMed |
spelling | pubmed-71761992020-04-22 Global Immunization Challenge: Progress and Opportunities Affolder, Rebecca Zaffran, Michel Lob-Levyt, Julian Maternal and Child Health Article After reading this chapter and answering the discussion questions that follow, you should be able to: Outline important milestones in the emergence of vaccines as a means of disease control and prevention. Discuss factors that underpin the disparity in access to vaccines between rich and poor countries. Identify and appraise innovative options for financing vaccine development, and for ensuring wider access to new and underused vaccines in developing countries. Evaluate strategies for ensuring sustainability in vaccine development, management, and access. Outline priorities for future research, policy, and practice with regard to vaccine development, procurement, and access. 2009-05-18 /pmc/articles/PMC7176199/ http://dx.doi.org/10.1007/b106524_23 Text en © Springer Science+Business Media, LLC 2009 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Affolder, Rebecca Zaffran, Michel Lob-Levyt, Julian Global Immunization Challenge: Progress and Opportunities |
title | Global Immunization Challenge: Progress and Opportunities |
title_full | Global Immunization Challenge: Progress and Opportunities |
title_fullStr | Global Immunization Challenge: Progress and Opportunities |
title_full_unstemmed | Global Immunization Challenge: Progress and Opportunities |
title_short | Global Immunization Challenge: Progress and Opportunities |
title_sort | global immunization challenge: progress and opportunities |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176199/ http://dx.doi.org/10.1007/b106524_23 |
work_keys_str_mv | AT affolderrebecca globalimmunizationchallengeprogressandopportunities AT zaffranmichel globalimmunizationchallengeprogressandopportunities AT loblevytjulian globalimmunizationchallengeprogressandopportunities |